Scientific evidence for the control of antimicrobial resistance

Vista sencilla de ítem
dc.contributor.authorAlpuche Aranda, Celia Mercedes
dc.contributor.authorArias, César A.
dc.contributor.authorTejada, Carlos Espinal
dc.contributor.authorSalguero Tejada, Carlos
dc.contributor.authorForde, Corey
dc.contributor.authorPark, Benjamin
dc.contributor.authorRossi, Flávia F.
dc.contributor.authorThormann, Monica
dc.date.accessioned2021-02-13T15:48:37Z
dc.date.available2021-02-13T15:48:37Z
dc.date.issued2020
dc.description.abstractenglish[Extract]. Antimicrobial resistance (AMR) is one of the greatest global threats to human health. It is estimated that by 2050, AMR will lead to approximately 10 million annual deaths worldwide. Considering the impact of AMR on reproductive capacity and food production, in addition to its direct effect on infected people, the world's population could drop by between 11 and 444 million inhabitants by 2050 if AMR control is not achieved. As migrations and shared economies lead to the transmission of resistant bacteria across borders, the impacts of AMR become regionally significant. In the United States, methicillin-resistant Staphylococcus aureus caused 10 600 deaths in 2017. In Latin American and Caribbean countries, information is available from studies conducted in hospitals and other health facilities on the prevalence of antimicrobial-resistant pathogens. In many hospitals in Mexico, Peru, and Colombia, for example, resistance to third-generation cephalosporins and fluoroquinolones in Escherichia coli isolates is reaching almost 60%. Moreover, the dynamics of colonization and infection of multidrug-resistant organisms (such as carbapenemaseproducing Klebsiella pneumoniae) are unique in endemic areas of Latin America, favoring spread and dissemination. [...]eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.26633/RPSP.2020.128
dc.identifier.instnameinstname:Universidad El Bosquespa
dc.identifier.issn1680-5348
dc.identifier.reponamereponame:Repositorio Institucional Universidad El Bosquespa
dc.identifier.repourlrepourl:https://repositorio.unbosque.edu.co
dc.identifier.urihttps://hdl.handle.net/20.500.12495/5315
dc.language.isoeng
dc.publisherPan American Health Organization/Organizacion Panamericana de la Saludspa
dc.publisher.journalRevista panamericana de salud publica/Pan american journal of public healthspa
dc.relation.ispartofseriesRevista panamericana de salud publica/Pan american journal of public health, 1680-5348, Vol. 44, 2020spa
dc.relation.urihttps://iris.paho.org/handle/10665.2/53141
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.accessrightshttps://purl.org/coar/access_right/c_abf2
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.rights.accessrightsAcceso abierto
dc.rights.creativecommons2020-12-11
dc.rights.localAcceso abiertospa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.decsResistencia a medicamentosspa
dc.subject.decsKlebsiella pneumoniaespa
dc.subject.decsEscherichia colispa
dc.titleScientific evidence for the control of antimicrobial resistancespa
dc.title.translatedScientific evidence for the control of antimicrobial resistancespa
dc.type.coarhttps://purl.org/coar/resource_type/c_6501
dc.type.driverinfo:eu-repo/semantics/article
dc.type.hasversioninfo:eu-repo/semantics/publishedVersion
dc.type.localArtículo de revista

Archivos

Bloque original
Mostrando 1 - 1 de 1
Miniatura
Nombre:
Alpuche Aranda CM, Arias CA_2020.pdf
Tamaño:
238.03 KB
Formato:
Adobe Portable Document Format
Descripción:
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar

Colecciones

Artículos